Thyroid tumor-promoting effects of iodine deficiency and iodine excess were investigated in a rodent 2-stage model to estimate an optimal iodine intake range that would not effectively promote development of thyroid neoplasia. Six-week-old male F344 rats were given a single subcutaneous injection of 2,800 mg/ kg body weight N-bis(2-hydroxypropyI)-nitrosamine (DHPN) or saline vehicle, maintained on Remington's iodine-deficient diet (21 k 2 ng/g iodide), and supplemented with various amounts of potassium iodide up to 260 mg/liter in drinking water to generate conditions ranging from severe iodine deficiency to severe iodine excess. In DHPN-treated rats, both conditions significantly increased thyroid follicular tumorigenesis. In DHPN-untreated rats, iodine deficiency produced diffuse thyroid hyperplasia, characterized by small follicles with tall epithelium and reduced colloid, together with a decrease in thyroxine (T4) and an increase in thyroid-stimulating hormone (TSH). On the other hand, iodine excess produced colloid goiter, characterized by large follicles with flat epithelium and abundant colloid admixed with normal or small-sized follicles lined by cpithelium of normal height, together with normal serum T4 and slightly decreased TSH. These effects were directly proportional to the severity of iodine deficiency or extent of iodine excess and suggest that each condition has a different thyroid tumor promotion mechanism. Iodine intakes that showed the least tumor promotion were 2.6 and 9.7 pg/rat/day in this study. Promoting mechanisms and the problem of statistically estimating recommended daily iodine intake range are briefly discussed.
INTRODUCTION
18-1,000 mg iodine per day, and iodine intake of Thyroid-stimulating hormone (TSH) is known to induce thyroid hyperplasia, characterized by small follicles lined by tall follicular epithelium and reduced amounts of colloid, as well as thyroid tumors in rodents (20) . Iodine-deficient diets and thyroid hormone synthesis inhibitors are also known to produce thyroid tumors or promote thyroid tumorigenesis in a 2-stage rodent carcinogenesis model by increasing serum TSH via a negative feedback mechanism involving the pituitary-thyroid axis (3, 27, 28, 38) .
On the other hand, various clinical and experimental data have been reported concerning the effect of excess iodine on thyroids. Iodide goiters in human adults are induced by prolonged intake of "coast goiter" patients in Hokkaido, Japan, is estimated as 200 mg/day (56) . Prolonged excess iodine intake of pregnant mothers places newborns at risk of iodide goiter (39, 49, 56) . The amount of daily dietary iodine intake from all sources is therefore clearly an important factor affecting human health.
To gain insight into the human health effects of dietary iodine, the present study was undertaken to estfirpate the optimal iodine intake dosage that would be noneffective fir thyroid. tumor promotion in a 2-stage model using rats initiated with N-bis(2-hy-droxypropy1)-nitrosamine (DHPN). Included are assessments of hormonal status and histopathologic changes associated with various levels of iodine intake ranging from severe deficiency to severe excess. Three experiments were conducted in series, allowing the thyroid tumor-promoting effects of iodine deficiency and iodine excess to be comparatively evaluated in terms of histopathology, histometry, and serum levels of thyroid-stimulating hormone (TSH) and thyroxine (T4).
MATERIALS AND METHODS
In experiment no. 1, a total of 280 rats was divided into 14 groups of 20 rats each. Rats in groups 1-7 received a sc injection of 2,800 mg/kg DHPN (24) . Rats in groups 8-14 received a sc injection of saline. From week 2 to 26, all rats were allowed free access to the iodine-deficient diet and tap water in which different concentrations of KI were dissolved (Table I) . Daily iodine intake was estimated from assumed consumption of diet and water; amounts were assumed to be 20 g and 20 ml per rat per day. The iodine concentration for groups 5 and 12 (200 &liter) was adjusted to the reported nongoitrogenic intake level (ca. 3 pg/rat/day) for rats (45, 56) . Thus there were 4 levels of iodine deficiency and 2 levels of iodine excess in experiment no. 1. Aortic blood was collected under ether anesthesia for T4 hormone assays. All rats were euthanized by exsanguination under ether anesthesia and necropsied. The left thyroid lobes of 3 rats from each group were fixed in glutaraldehyde and osmic acid, embedded in epoxy resin, sectioned, double-stained with uranyl acetate and lead citrate, and observed with a JEOL CX-120 electron microscope.
In experiment no. 2,80 rats received a sc injection of 2,800 mg/kg body weight DHPN and were divided into 4 groups of 20 animals each. Iodinedeficient diet and ion-exchanged purified water supplemented with KI as shown in Table I1 were given from week 2. Daily iodine intake of group 4 was adjusted to be optimum (45, 56) . This experiment had 3 levels of iodine deficiency. At week 26, aortic blood was collected under ether anesthesia for TSH and T4 assays, and the rats were necropsied. In experiment no. 3, 80 rats were divided into 4 groups of 20 rats each. Groups 1 and 2 received a sc injection of 2,800 mg/kg DHPN, and groups 3 and 4 received saline vehicle. All groups were fed basal diet. Rats in groups 1 and 3 received tap water, yhereas groups 2 and 4 were given tap water containing 200 mg/fiter KI to generate an iodine excess condition for 20 weeks. All rats were anesthetized for aortic blood collection and necropsied.
Histological and Histometrical Exaiiiiiiatioii
Thyroids and pituitaries were fixed in neutral buffered formalin. Paraffin sections were cut at 4 pm and stained with hematoxylin and eosin.
As previously reported (27) , in order to keep correspondence with histological characteristics of human thyroid tumors (23), we classified rat thyroid > *. . : r Weight of 8 rats that survived 20 weeks. Average weight of 20 rats at necropsy is 227.9 k 29.8 g.
'Including 12 rats that died before week 20. All 8 rats that survived 20 weeks had NI lesions.
Calculation based on average consumption of 12.1 k 0.2 g diet and 15.3 k 0.3 ml water/rat/day in Exp. no. 1.
One C-cell tumor excluded.
nodular lesions into 4 categories as follows: 1) adenomatous nodules (AN), comparable to adenomatous goiter nodules or hyperplastic nodules in man; 2) adenomatous goiter (AG) ( Fig. la) , designated in cases of multiple adenomatous nodules (>4 nodules per lobe); 3) thyroid neoplasia (N) ( Fig. 1 b) , nodular lesions composed of atypical epithelial growth distinguished from and without transition to the sur- rounding thyroid tissue; and 4) thyroid neoplasia with apparent invasion (NI) into the adjacent thyroid or extrathyroidal tissues. This sequence is associated with increasing malignant progression of the induced lesions (cf. fig. 1 in Kanno et a1 (27)). C-cell hyperplasia and neoplasia were not considered in this study. As a quantitative index for diffuse morphologic changes induced in DHPN-untreated rat thyroids, the percentage of total thyroid area occupied by follicular epithelial cells designated as percentage of follicular tissue area (Yo FTA) was measured by a TAS-plus image analyzer (Leitz Wetzlar, West Germany). In general, a high percentage for FTA indicates depletion of colloid with follicular cellular hyperplasia, whereas a low percentage for FTA generally indicates colloid goiter (27) .
Hormone Assay
Serum T4 was measured by the Enzymun-Test 
Statistical Analysis
Effects of iodine deficiency and iodine excess conditions on production of thyroid nodular lesions in DHPN-treated rats were assessed separately by the Cochran-Armitage normal deviate test for trend (1tailed) (2, 18 
RESULTS
In experiment nos. 1 and 3, all rats survived throughout the experimental period, whereas in experiment no. 2, 12 of 20 rats (group 1) subjected to the lowest iodine intake became moribund or died with markedly swollen thyroids before the scheduled termination (ion-exchange water was used in Exp. no. 2, whereas tap water, which may have contained trace levels of various elements was used in Exp. nos. 1 and 3) . Body weights, thyroid weights, and iodine intake of rats in experiment nos. 1, 2, and 3 are shown in Tables I, 11 , and 111, respectively. Daily iodine intake of rats in this study was calculated from the diet and water consumption data from experiment no. 1 (data not shown). The diet and water consumption decreased linearly with animal age. Total water consumption was slightly less in iodine-deficient and iodine-excess groups than in the adequately iodine-supplemented group, and it was slightly less in DHPN-treated groups than in DHPN-untreated groups. Similar tendencies were not clear for total diet consumption. Averages of total consumption ofdiet and water among 14 groups in experiment no. 1 were 12.1 f 0.2 (SD) g/rat/day and 15.3 f 0.3 ml/rat/day, respectively. Because the SD values were small, we adopted 12.1 g diet and 15.3 ml water as average consumption per rat per day for all 3 experiments.
Findings for Rats with Adequate Iodine Intake
Only 2 of 60 DHPN-treated rats given either iodine-deficient diet with water containing KI at a concentration of 200 pg/liter (Exp. no. 1, group 5; and Exp. no. 2, group 4) or basal diet (Exp. no. 3, group 1) developed thyroid neoplasia (Tables 1-111) . Thyroid weight, thyroid histology, pituitary histology, and serum level T4 ofrats with adequate iodine intake were comparable with those of untreated rats maintained under standard conditions on basal diet in our laboratory (27) . TOXICOLOGIC PATHOLOGY ("/ . I 
Eflects of Iodine Deficieiicy
In a severity-dependent manner, iodine deficiency significantly increased the development of thyroid neoplasia in DHPN-treated rats in both experiment nos. 1 and 2 (Tables I, 11 , and Fig. 2 ). Frequencies of adenomatous nodules and adenomatous goiters were also increased by iodine deficiency. Serum T4 decreased and TSH increased as the iodine deficiency increased.
In DHPN-untreated rats, thyroid enlargement was proportional to the severity of iodine deficiency. Histologically, the thyroids were diffusely hyperplastic with small follicles, tall follicular epithelial cells, and reduced amounts of colloid (Fig. 3a) . The Yo FTA increased in proportion to the degree of iodine deficiency ( Fig. 4) and was associated with a decrease in T4 (Table I) . Pituitary glands of the iodine-deficient rats were significantly heavier (9.15 f 0.91 mg, Exp. no. 1, group 8) than those of optimally supplemented rats (8.55 f 0.86 mg, Exp. no. 1, group 12, p < 0.05) and histologically contained many swollen "thyroidectomy cells" with abundant, pale homogeneous cytoplasm and an eccentric nucleus, indicating hypersecretion of TSH (31) .
Eflects of Iodiiie Excess
Thyroid neoplasia was significantly increased in DHPN-treated rats given excess iodine (p < 0.03 for data from Exp. no. 1, groups 5, 6, and 7, and Exp. no. 3, groups 1 and 2, by a combined 1-tailed trend test) (Fig. 2) . Histological characteristics of these neoplasia were indistinguishable from those seen in DHPN-treated iodine-deficient rats. Serum T4 remained unchanged, and TSH showed a slight tendency to decrease. Adenomatous nodules and adenomatous goiters were also increased in direct proportion with the iodine dosage.
In DHPN-untreated rats, thyroid weight remained unchanged with increased iodine intake. Although the thyroids were not significantly swollen, histological examination revealed features of colloid goiter, characterized by colloid-rich large follicles with flat follicular epithelium admixed with normal or small-sized follicles lined by normal epithelium (Fig. 5a ). Ultrastructurally, the flat epithelium of the colloid-rich follicles had small numbers of microvilli and atrophic cytoplasmic organelles, strongly suggesting that the cells are hypofunctional (Fig. 5b) . Ultrastructural features of epithelial cells of normal or small-sized follicles were indistinguishable from those of normal functioning thyroid follicular cells in nontreated rats. The overall Yo FTA was reduced in the iodine-excess condition (Fig. 4) . T4 was not decreased and TSH was not increased by excess iodine (Tables I and 111 ). The pituitaries were not enlarged (8.74 0.85 mg, Exp. no. 1, group 14) compared to optimally supplemented rats (8.55 k 0.86 mg, Exp. no. 1, group 12), and they were histologically unremarkable.
DISCUSSION
In the present study, both iodine deficiency and iodine excess promoted thyroid carcinogenesis in the rodent 2-stage tumor model. Histopathologic and hormonal changes induced by iodine deficiency are compatible with the proposed mechanism that iodine deficiency induces hyperthyrotropinemia via a negative feedback mechanism involving the pituitary-thyroid axis and that the increased TSH promotes thyroid tumorigenesis (3, 27, 28, 38) .
Physiological effects of excess iodine have been studied extensively. A large dose of iodine induces acvtehjrpothyroidism, associated with a decrease in serum T4, followe'd by an increase in serum TSH in rodents and humans. This acute phenomenon is known as the Wolff-Chaikoff effect (35, (56) (57) (58) . It is explained that sustained increase in intracellular iodide concentration (7, 35, 56) by excess iodine intake inhibits thyroglobulin hydrolysis (4), its own organic binding (35, 37, 58) , hydrogen peroxide production @), or the generation of cyclic AMP (43, 52) . Morphological changes are not observed in this acute phase.
Prolonged administration of excess iodine has various effects on thyroid and thyroid-related hormones. Either hypothyroidism persists or thyrotoxicosis may be induced (56) . In most instances, however, the euthyroid state is restored with normalization of serum TSH levels. This is called the escape phenomenon from the Wolff-Chaikoff effect. Measured by restoration of lZsI incorporation, it takes place within 50 hr in rats (58) . An expla. nation of this phenomenon is that a TSH-independent, intrinsic mechanism reduces the thyroidal iodide-transport capacity, thereby lowering the intrathyroidal iodide concentration to a level insufficient to sustain the Wolff-Chaikoff effect (7). Morphologically, chronic excess iodine intake induces colloid goiter, composed of large follicles lined by flattened epithelial cells admixed with normallooking follicles (10, 14, 56, 58) .
The tumor-promoting mechanism of excess iodine, however, is not well studied. To our knowl-edge, no report has been published. In this study, a transient rise in serum TSH induced by the Wolff-Chaikoff effect is presumably too short for a significant increase in tumor yield (58) . According to the morphology and hormone titers, it is more likely that the escape phenomenon from the Wolff-Chaikoff effect had been maintained in iodine-excess rats $.!his study. Our present assumption is that the escape phenomehon from. Wolff-Chaikoff effect is related to the thyroid tumor-promoting effect. Further ongoing studies are focused on normal-looking follicles in colloid goiter induced by iodine excess.
Many chemicals covalently bind iodide; Erythrosine (FD&C Red No. 3 or 2,4,5,7-tetraiodo-fluorescein disodium salt), Rose Bengal B (FD&C Red No. 105 or 3,4,5,6-tetrachloro-2',4',5',7 '-tetraiodofluorescein sodium salt), amiodarone, and ipodate have been reported to act as adventitious sources of iodine (1, 6, 11, 17, 19, 42, 53) and to cause TOXICOLOGIC PATHOLOGY 40 hypothyroidism (21, 30, 33, 34, 42) , thyrotoxicosis (42, 48) , or colloid goiter (9, 26). Erythrosine and Rose Bengal B are also reported to induce thyroid neoplasia in rodent bioassays (26,5 1) . Because there are reports that many iodinated compounds are inhibitors of 5'-deiodinase and block the conversion ofT4 to 3,5,3'-triiodithyronine (T3) (30,47,5 1,59) , these compounds have been regarded to induce thyroid tumors by increased serum TSH level via the thyroid-pituitary axis feedback mechanism responding to the decrease in T3 level (51) . In an in vitro assay using a dog thyroid microsome fraction, KI did not inhibit deiodinase activity, showing that molecular structures of iodide-containing compounds have specific activities on deiodinase (59) . However, in a chronic in vivo experiment in rats, excess iodide inhibited reutilization of intrathyroidal iodide (36) . Therefore, there is a distinct possibility that excess iodine may mimic the effects of deiodinase inhibitors in in vivo assay systems. In this regard, some iodine-containing chemicals might have induced thyroid tumors in rodent bioassays by the mechanism of excess iodine (27) .
Epidemiologically, human thyroid cancers correlate with inadequate daily iodine intake or occurrence of endemic goiter (5, 13, 15, 16, 22, 40, 46, 50, 54, 55) . The amount of iodine intake from all sources is therefore an important dietary factor to be considered for health. Optimal iodine intake in man calculated from the daily secretion rates of T3 and T4 from the thyroid is approximately 200 pg/ day (56) . The National Academy of Science (25) reported that, in humans, 100-300 &day is generally accepted as desirable, and 50-1,000 &day is estimated to be safe. For safety purposes, the FAO/ WHO Joint Expert Meeting on Food Additives set a provisional maximal tolerable daily intake of 1 .O mg iodine/day from all sources (5 1).
Optimal iodine intake in rats can be estimated as the noneffective level or the least effective levels from the U-shaped thyroid tumor dose response curve in this study (Fig. 2) , although the tumor promotion mechanisms are probably different in iodine-deficiency and iodine-excess conditions. The least effective daily intake doses for thyroid tumor promotion in this study were 2.6 and 9.7 &rat/ day. These 2 values are comparable to recommended dietary intake values in humans when compared by the body weight or by the body surface area that correlate with the basal metabolic rate. A ratio of 70 kg (human adult) to 0.35 kg (F344 adult rat) that is 200 to 1 in body weight gives least effective daily intake dose estimates of 520 and 1,940 pg iodine/ humadday. Roughly estimating that the shape and specific gravity of human and rat bodies are identical, a ratio of 200 to 1 in body weight corresponds to 200u3 to lU3, or 34 to 1 in body surface area; this gives 88 and 330 pg iodine/humadday. Before extrapolation of rat data to humans is undertaken, mathematical evaluation of the optimal iodine intake range in rats should be performed. However, known mathematical models such as those for virtually safe dose (VSD) estimation (29, 32) utilized in cancer risk assessment are not designed for U-shaped dose-response curves, as in Fig. 2 . Application of these models to a monotonic half of the U-shaped curve results in unrealistic VSD values. For example, the iodine excess portion of Fig.  2 generates 2 x pg/rat/day by 1-hit model, 5 x lo-' pg/rat/day by probit, 8 x pg/rat/day by logit, and 4 x pg/rat/day by Weibull for the upper limit of iodine intake. New mathematical models for U-shaped curves are needed.
In summary, both iodine deficiency and excess promoted thyroid tumorigenesis in the 2-stage model. This study confirmed that iodine deficiency promotes tumorigenesis by increase in serum TSH via negative feedback involving the thyroid-pituitary hormonal axis. Furthermore, this study proposes that the effects ofekcess iodine in promoting thyroid tumorigenesis differ mechanistically from those of iodine deficiency. For iodine excess, we postulate a relationship to the escape phenomenon from the Wolff-Chaikoff effect. In addition, it has been speculated that some iodine-containing thyroid carcinogens might have acted via an excess iodine mechanism (26, 27) . In conclusion, the least effective daily intake doses obtained in a rat 2-stage carcinogenesis model were comparable to the reported iodine intake ranges associated with noncancerous endpoints
